todralazine (Compound)

Synonyms:todralazine, 14679-73-3, Todralacina, Todralazina, Ecarazine, Carboethoxyphthalazinohydrazine, Ethyl 3-(1-phthalazinyl)carbazate, BT 621, CARBAZIC ACID, 3-(1-PHTHALAZINYL)-, ETHYL ESTER, 3-(1-Phthalazinyl)carbazic acid ethyl ester, Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, WEN3K83YKD, CEPH [AS HYDROCHLORIDE], Binazin, BT 621 [AS HYDROCHLORIDE], NSC-757868, Todralacina [Spanish], Todralazinum, Todralazine [INN:BAN], Todralazinum [INN-Latin], Todralazina [INN-Spanish], NCGC00016640-03, UNII-WEN3K83YKD, CAS-3778-76-5, N-Carboethoxy-N'-phthalazino-hydrazine, BRN 0233300, Todralazine (BAN), CEPH, Binazine (Salt/Mix), ethyl N-(phthalazin-1-ylamino)carbamate, Ecarazine (Salt/Mix), CEPH FREE BASE, Spectrum_001187, Todrazoline (Salt/Mix), TODRALAZINE [MI], Prestwick0_000071, Prestwick1_000071, Prestwick2_000071, Prestwick3_000071, Spectrum2_001147, Spectrum3_000932, Spectrum4_001031, Spectrum5_001223, TODRALAZINE [INN], BT-621 FREE BASE, SCHEMBL49644, BSPBio_000281, KBioGR_001581, KBioSS_001667, TODRALAZINE [WHO-DD], 5-25-17-00414 (Beilstein Handbook Reference), DivK1c_000506, SPBio_001073, SPBio_002202, BPBio1_000311, CHEMBL1079787, DTXSID0045048, CHEBI:94706, KBio1_000506, KBio2_001667, KBio2_004235, KBio2_006803, KBio3_001964, NINDS_000506, HY-B1001, CS-4498, NSC 757868, IDI1_000506, NCGC00016640-01, NCGC00016640-02, 1-(N'-ethoxycarbonylhydrazino)phthalazine, DA-10133, SBI-0051674.P002, AB00053609, FT-0737585, D08613, Ethyl 2-(1-phthalazinyl)hydrazinecarboxylate #, AB00053609_08, N-(1-phthalazinylamino)carbamic acid ethyl ester, CU-00000000398-1, BRD-K68553471-003-04-0, BRD-K68553471-003-07-3, Q27166508

Pubchem:PUBCHEM:5501

Id:6845a3ad-3912-52e8-b32e-06997704a7aa

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View todralazine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for todralazine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with todralazine.

Results found

Linked to

	Label	Description
	BRD-K68553471-003-07-3 Substance (Entity type)	A Substance
	DCSTRUCT ID 02691 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02691; PubChem_CID:5501, FILE=drugcentral_drug_02691.json)
	todralazine positively regulates IARS2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	todralazine negatively regulates DLK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	todralazine positively regulates S100A10 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	todralazine positively regulates KCTD12 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	todralazine negatively regulates ID3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	todralazine positively regulates P4HTM Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	todralazine in similarity relationship with fluoropyruvate Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	todralazine positively regulates MAFB Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS